Search

TransMedics Group Inc

Fermé

SecteurSoins de santé

86.41 -0.16

Résumé

Variation du prix de l'action

24h

Actuel

Min

85.44

Max

86.89

Chiffres clés

By Trading Economics

Revenu

7.4M

15M

Ventes

16M

190M

P/E

Moyenne du Secteur

22.244

56.432

BPA

0.44

Marge bénéficiaire

7.729

Employés

898

EBITDA

-889K

27M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+9.03% upside

Dividendes

By Acuity

Prochains Résultats

28 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

159M

3B

Ouverture précédente

86.57

Clôture précédente

86.41

Sentiment de l'Actualité

By Acuity

50%

50%

106 / 339 Classement par Healthcare

TransMedics Group Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 sept. 2026, 20:06 UTC

Transmedics Group Inc shares fell, closing below Thursday's level after fluctuating throughout the day, marking three consecutive sessions of lower closes.

17 sept. 2026, 20:07 UTC

Transmedics Group Inc shares fell Thursday, declining from Wednesday's close despite a brief earlier rebound, amid overall lower market performance.

16 sept. 2026, 20:10 UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

15 sept. 2026, 20:07 UTC

Social Media

TransMedics Group shares are rising following an insider purchase by Director David Weill at $81.63, amid positive social media discussions about the company.

14 sept. 2026, 20:03 UTC

TransMedics Group Inc shares are gaining during Monday's session, despite earlier pullbacks. Broader market volatility is influenced by rising crude oil prices and inflation concerns.

11 sept. 2026, 20:02 UTC

News
Event
Social Media

TransMedics Group Inc shares are lower following the announcement of a CFO transition. The company reaffirmed its 2026 revenue guidance of $737 million to $757 million.

10 sept. 2026, 20:06 UTC

Transmedics Group Inc shares are lower amid broader market pressure, reflecting ongoing concerns over rising Treasury yields and inflation. No specific company news was identified.

9 sept. 2026, 20:07 UTC

Social Media

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8 sept. 2026, 19:56 UTC

News
Social Media

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4 sept. 2026, 20:07 UTC

News

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2 sept. 2026, 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1 sept. 2026, 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.

31 août 2026, 20:03 UTC

Transmedics Group Inc shares are declining amid broader economic concerns following remarks from Warsh at the Jackson Hole Economic Symposium.

28 août 2026, 20:07 UTC

Transmedics Group Inc shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and no specific company news identified.

27 août 2026, 19:16 UTC

Transmedics Group Inc. shares are lower amid broader market concerns about persistent U.S. inflation, despite a brief midday rebound earlier in the session.

26 août 2026, 21:36 UTC

Transmedics Group Inc. shares declined slightly in after-market trading, reflecting broader market caution ahead of Nvidia's earnings report and recent inflation data.

25 août 2026, 19:46 UTC

TransMedics Group Inc is trading lower today, with no specific news identified. The stock remains near its one-month range's upper end.

24 août 2026, 23:06 UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

21 août 2026, 19:36 UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

20 août 2026, 19:46 UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

19 août 2026, 23:11 UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

18 août 2026, 19:16 UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

13 août 2026, 19:52 UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

12 août 2026, 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

11 août 2026, 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

10 août 2026, 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

7 août 2026, 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6 août 2026, 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5 août 2026, 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4 août 2026, 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

Comparaison

Variation de prix

TransMedics Group Inc prévision

Objectif de Prix

By TipRanks

9.03% hausse

Prévisions sur 12 Mois

Moyen 94.222 USD  9.03%

Haut 122 USD

Bas 65 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

7

Achat

4

Maintien

0

Vente

Sentiment

By Acuity

106 / 339Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.